Dudediligence.

Replimune Group, Inc

REPLNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price

From the filings

Figures

Net income
−$297.0Mlast 12 months
Operating cash flow
−$279.1Mlast 12 months
Cash and equivalents
$185.4Mat the last balance sheet
Total debt
$84.1Mat the last balance sheet
Shares outstanding
84.0M shareson issue
Every year and quarter →